AIPLA Comments on the USPTO in Response to the Interim Process for Director Review
All documents are in PDF format.
On July 11, the American Intellectual Property Law Association (AIPLA) offered its initial views to the United States Patent and Trademark Office (“USPTO”) in response to the Interim Process for PTAB Director Review. AIPLA appreciates the USPTO’s focus on improving fairness to all parties and achieving greater consistency and predictability in these proceedings.
AIPLA recognizes the USPTO’s efforts to adopt a transparent process for Director review. It is AIPLA’s belief that the Patent Trial and Appeal Board (PTAB) decision-making should be transparent to ensure accountability and facilitate review on appeal. AIPLA notes some additional issues that could be clarified before the final Request For Comments is issued, including, providing examples of issues and explanations that would be appropriate for a Rehearing Request by the Director (with respect to “Focusing and Prioritizing Issues”), and identifying the issues that will be considered in the Director Review.
Such transparency surrounding PTAB decision-making is important to promote public confidence and we note that several aspects of the process could use clarification. We suggest staggering the terms of Circulation Judge Pool judges to improve institutional knowledge and consistency and credit members of the CJP, ensuring they have sufficient time and resources to thoroughly review their decisions.
2024 Trade Secret Summit
March 14 to 15, 2024Registration is now Open! Please join the AIPLA Trade Secret Committee for the 2024 Trade Secret Summit, which is being held March 14-15, 2024 in Santa Clara, California. The AIPLA Trade Secret Summit is the leading trade secret conference in the nation, with speakers from across the spectrum of private practitioners, in-house counsel, government, and academia, as well as fantastic networking opportunities. Registration is now open!
2024 Advanced Chemical Patent Practice Institute
May 14 to 15, 2024This advanced course offers how the chemical/pharma patent practitioners can use fundamentally sound but oft overlooked principles to prepare and prosecute a United States chemical/pharma patent application to withstand both PTAB and district court challenges. The principles taught will greatly help those advanced chemical/pharma patent practitioners involved with prelitigation, portfolio management, litigation, Orange Book listings, Purple Book/BCPIA, regulatory practice, due diligence, health checks, and analysis of third-party patents for validity/patentability, infringement, and enforceability issues, as well as for preparing IPR and/or PGR petitions and defending the patent against them.
AIPLA 2024 Spring Meeting
May 16 to 18, 2024Join us as we bring IP professionals together to learn and connect. More information coming soon! The 2024 Spring meeting will take place in downtown Austin, at the Hilton Austin. Leadership Meetings on Wednesday, May 15. Programming scheduled May 16-18.